You searched for "invasive"
2018 update on intravitreal injections
1 December 2018
| Sofia Rokerya
|
EYE - Vitreo-Retinal
In this review article the authors have highlighted the standardised and structured approach to intravitreal injections (IVI) by examining the recent evidence-based literature. IVI is the most commonly performed procedure worldwide with low potential risk of endophthalmitis. IOP spikes are...
OCTA in diabetic macular oedema treated with intravitreal aflibercept (DOCTA Study)
3 April 2024
| Sofia Rokerya
|
EYE - Vitreo-Retinal
Central vision loss due to diabetic macular oedema (DME) can be attributed not only to presence of the macular oedema itself but also, in some cases, to alterations of the foveal avascular zone (FAZ). The DOCTA trial was a longitudinal,...
Pioneering accessible technology conference returns to Glasgow in 2025
RNIB Scotland’s Inclusive Design for Sustainability (IDS) Conference is set to return to Glasgow Science Centre on 17 and 18 March 2025, bringing together global tech giants and accessibility advocates to explore the future of inclusive design. The event, which...Hot debates in medical retina and imaging: Perspectives from the Controversies in Ophthalmology 2020 virtual conference
Controversies in medical retina and imaging were debated during the Controversies in Ophthalmology 2020 virtual conference held during two mid-day scientific sessions on 27 and 28 March 2020. The author recounts key perspectives and presents viewpoint recommendations from the Vision...
Medical management and diabetic retinopathy progression
1 February 2015
| Brian Ang
|
EYE - Vitreo-Retinal
The ACCORD Eye Study was designed to evaluate the benefit of intensive glycaemic control (HbA1c <6.0% vs 7.0-7.9%), intensive systolic blood pressure control (<120mmHg vs. <140mmHg), and combined fenofibrate and simvastatin therapy in the development and progression of diabetic retinopathy....
Dry eye disease treatments come to the fore at 100%
Guidance on setting up, or enhancing, a Dry Eye disease clinic within the practice will be freely available from OSA members exhibiting at 100% Optical: 1–3 March. The ability to diagnose and treat a major irritation for many is winning...Informed consent in ophthalmology care in the UK: A critical component of patient‑centred practice
2 April 2025
| Ali Yagan
|
EYE - General
Informed consent is a cornerstone of ethical and legal practice in healthcare, particularly in fields like ophthalmology where specialised interventions can have significant implications for a patient’s vision and quality of life. In the UK, informed consent is not merely...
Technology in ophthalmology – a promising future and what we need to know about the regulations
1 October 2017
| Priya Nidamanuri, Magdalena Popiela
|
EYE - Cataract, EYE - Refractive, EYE - Cornea, EYE - Glaucoma, EYE - Imaging, EYE - Orbit, EYE - Vitreo-Retinal, EYE - General
Undoubtedly, ophthalmology is one of the greatest sources of inspiration for technological progress in medicine. Thus far, we have seen remarkable advancements in the technology used by ophthalmologists across all subspecialties. From simplifying common procedures, to treating previously incurable conditions,...
Hear from the RCOphth Subcommittee
26 May 2022
We heard from Dr Swetha Maddula Batambuze, SAS Chair RCOphth, and the rest of the RCOphth subcommittee about their Invisible Ophthalmologist talk yesterday, and their plans for the SAS Forum in November.
Intensive diabetes therapy and ocular surgery in type 1 diabetes
1 October 2015
| Jonathan CP Roos
|
EYE - Vitreo-Retinal
The Diabetes Control and Complications Trial (DCCT) ran between 1983 and 1993 and showed that intensive glycaemic control was beneficial in reducing diabetic retinopathy in type 1 patients. There was a 76% reduction in onset of retinopathy and a 52%...
